Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02717234
Other study ID # 14.31.US.CLI
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2016
Est. completion date May 2016

Study information

Verified date March 2016
Source Société des Produits Nestlé (SPN)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the effect of consumption of an oral nutrition supplement on Arginine, a blood marker of nutritional intake


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Healthy subject (absence of metabolic disorder, heart disease, endocrine disease, cancer) - Discontinued use of omega 3 fatty acid supplements - 10 days prior to testing - Willing to provide signed informed consent Exclusion Criteria: - Smoker - Patients with potential for non-compliance - Patients with allergy to ingredients in test products (i.e. milk protein, fish oil) - Subject who in the Investigator's assessment cannot be expected to comply with study protocol - Currently participating in another conflicting clinical trial.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Oral Nutrition Supplement
Oral nutrition supplement intended for consumption at 3 servings per day

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Société des Produits Nestlé (SPN)

Outcome

Type Measure Description Time frame Safety issue
Other Change in plasma-free phospholipid Docosahexaenoic acid (DHA) in µg/ml Pre-consumption, 30, 60, 120, 180, 240 minutes
Other Change in plasma phospholipid Docosahexaenoic acid (DHA) in µg/ml Pre-consumption, 30, 60, 120, 180, 240 minutes
Primary Change in plasma arginine levels in µmol/L Pre-consumption, 30, 60, 120, 180, 240 minutes
Secondary Change in plasma-free phospholipid Eicosapentaenoic acid (EPA) in µg/ml Pre-consumption, 30, 60, 120, 180, 240 minutes
Secondary Change in plasma phospholipid Eicosapentaenoic acid (EPA) in µg/ml Pre-consumption, 30, 60, 120, 180, 240 minutes
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1